Last Close
Jun 03  •  04:00PM ET
137.40
Dollar change
+2.35
Percentage change
1.74
%
Jun 03, 7:35 AMAgilent gets FDA approval to expand PD-L1 IHC 22C3 pharmDx use on Dako Omnis for four additional Keytruda companion diagnostic cancer indications
Index
S&P 500
P/E
27.60
EPS (ttm)
4.98
Insider Own
0.33%
Shs Outstand
282.22M
Perf Week
18.61%
Market Cap
38.81B
Forward P/E
20.84
EPS next Y
6.59
Insider Trans
-0.17%
Shs Float
281.49M
Perf Month
22.48%
Enterprise Value
40.35B
PEG
2.26
EPS next Q
1.49
Inst Own
92.75%
Perf Quarter
13.99%
Income
1.41B
P/S
5.37
EPS this Y
8.39%
Inst Trans
-0.11%
Perf Half Y
-8.46%
Sales
7.23B
P/B
5.44
EPS next Y
8.82%
ROA
11.21%
Perf YTD
0.98%
Book/sh
25.24
P/C
21.48
EPS next 5Y
9.23%
ROE
21.33%
52W High
160.27 -14.27%
Perf Year
21.85%
Cash/sh
6.40
P/FCF
35.70
EPS past 3/5Y
3.03% 14.68%
ROIC
13.90%
52W Low
108.35 26.81%
Perf 3Y
16.22%
EV/EBITDA
21.27
Sales past 3/5Y
0.48% 5.41%
Gross Margin
52.79%
Volatility
4.01% 3.20%
Perf 5Y
0.76%
EV/Sales
5.58
EPS Y/Y TTM
22.77%
Oper. Margin
22.40%
ATR (14)
4.76
Perf 10Y
200.52%
Quick Ratio
1.62
Sales Y/Y TTM
9.11%
Profit Margin
19.55%
RSI (14)
76.45
Current Ratio
2.10
EPS Q/Q
58.79%
SMA20
14.96%
Beta
1.25
Debt/Eq
0.47
Sales Q/Q
10.01%
SMA50
17.11%
Rel Volume
1.28
Prev Close
135.05
Employees
18100
LT Debt/Eq
0.43
SMA200
5.80%
Avg Volume
2.27M
Price
137.40
IPO
Nov 18, 1999
Option/Short
Yes / Yes
Trades
Volume
2,928,272
Change
1.74%
Date Action Analyst Rating Change Price Target Change
May-28-26Upgrade BofA Securities Neutral → Buy $145
May-27-26Initiated RBC Capital Mkts Outperform $153
Jan-20-26Initiated HSBC Securities Buy $180
Jan-05-26Upgrade Evercore ISI In-line → Outperform $160
Dec-15-25Upgrade Barclays Equal Weight → Overweight $165
Dec-09-25Initiated Goldman Buy $170
Dec-02-25Initiated Morgan Stanley Overweight $270
Oct-08-25Upgrade UBS Neutral → Buy $170
Oct-08-25Initiated Rothschild & Co Redburn Buy $165
Feb-10-25Upgrade Barclays Underweight → Equal Weight $135 → $145
Jun-03-26 07:00AM
Jun-02-26 04:15PM
May-28-26 04:12PM
03:29PM
01:50PM
12:12PM Loading…
12:12PM
09:47AM
08:00AM
01:01AM
May-27-26 04:16PM
04:05PM
May-26-26 09:17AM
08:00AM
08:00AM
May-22-26 08:00AM
08:00AM Loading…
May-21-26 08:00AM
May-20-26 04:27PM
May-19-26 08:00AM
May-11-26 04:15PM
May-08-26 04:30PM
May-04-26 05:53PM
08:00AM
Apr-28-26 04:15PM
Apr-15-26 08:00AM
Apr-01-26 08:00AM
Mar-26-26 08:00AM
Mar-19-26 08:00AM
Mar-11-26 08:00AM
07:28AM
05:55AM
11:11AM Loading…
Mar-10-26 11:11AM
10:01AM
Mar-09-26 02:30PM
12:29PM
07:00AM
06:12AM
03:00AM
Mar-06-26 12:29PM
Mar-02-26 09:15AM
Feb-28-26 10:23PM
Feb-27-26 07:09AM
Feb-26-26 12:54PM
06:54AM
12:06AM
Feb-25-26 09:01PM
08:00PM
07:25PM
04:24PM
04:17PM
04:05PM
01:46AM
Feb-24-26 09:55PM
02:35PM
07:17AM
Feb-23-26 10:21PM
04:15PM
Feb-20-26 09:15AM
02:06AM
Feb-12-26 05:35PM
Feb-11-26 04:15PM
08:00AM
06:45AM
Feb-09-26 11:19AM
Feb-04-26 08:00AM
Feb-02-26 04:15PM
Jan-29-26 05:20PM
Jan-23-26 04:20PM
11:40AM
08:00AM
Jan-21-26 07:03AM
Jan-20-26 08:20PM
07:55AM
Jan-13-26 01:52PM
Jan-07-26 11:03AM
Jan-06-26 03:06PM
Dec-24-25 11:30AM
Dec-16-25 08:31AM
Dec-12-25 09:14AM
Dec-11-25 09:19AM
Dec-09-25 10:31PM
09:15AM
08:16AM
Dec-05-25 06:09AM
Dec-04-25 06:50AM
12:05AM
Dec-01-25 09:15AM
08:00AM
Nov-29-25 12:53PM
Nov-28-25 09:02AM
Nov-26-25 02:18PM
05:14AM
Nov-25-25 12:42PM
12:00AM
Nov-24-25 06:30PM
06:01PM
06:00PM
05:22PM
05:20PM
04:31PM
04:10PM
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Diagnostics Markets, Applied Markets, and Agilent CrossLab. The Life Sciences and Diagnostics Markets segment offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. The Applied Markets segment refers to the application-focused solutions that include instruments and software that enable customers to identify, quantify, and analyze the physical and biological properties of substances and products. The Agilent CrossLab segment spans the entire lab with its extensive services and consumables portfolio in addition to software and laboratory automation solutions. The company was founded in May 1999 and is headquartered in Santa Clara, CA.
CEOMr. Padraig McDonnell
VPMr. Rodney Gonsalves
Senior VP & President of Agilent CrossLab GroupMs. Angelica A. Riemann
Senior VP and President of Life Sciences & Diagnostics Markets GroupDr. Simon May
Senior VPMr. Adam S. Elinoff
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dolsten MikaelDirectorMay 29 '26Sale135.421,600216,6725,548Jun 02 04:01 PM
Dolsten MikaelDirectorMay 29 '26Proposed Sale135.421,600216,672May 29 04:45 PM
Dolsten MikaelDirectorDec 01 '25Sale149.812,600389,5114,973Dec 03 04:04 PM
Gonsalves RodneyV.P., Corporate ControllerNov 26 '25Sale154.993,000464,95631,846Dec 01 04:29 PM
Dolsten MikaelDirectorDec 01 '25Proposed Sale149.812,600389,510Dec 01 04:26 PM
Gonsalves RodneyOfficerNov 26 '25Proposed Sale154.993,000464,956Nov 26 02:26 PM
MCDONNELL PADRAIGPresident and CEONov 18 '25Sale143.24911130,49232,058Nov 20 05:22 PM
MCDONNELL PADRAIGOfficerNov 18 '25Proposed Sale143.24911130,492Nov 18 10:37 AM
MCDONNELL PADRAIGPresident and CEONov 12 '25Option Exercise109.8612,4901,372,15145,938Nov 14 04:02 PM
MCDONNELL PADRAIGPresident and CEONov 12 '25Sale150.0012,4901,873,50033,448Nov 14 04:02 PM
MCDONNELL PADRAIGOfficerNov 12 '25Proposed Sale150.0012,4901,873,500Nov 12 10:03 AM
McMahon Robert W.Former OfficerSep 09 '25Proposed Sale126.215,781729,591Sep 09 04:26 PM
McMahon Robert W.Former OfficerSep 04 '25Proposed Sale128.6215,3031,968,224Sep 04 04:39 PM
MCDONNELL PADRAIGPresident and CEOSep 02 '25Sale124.882,000249,76033,448Sep 04 03:36 PM
MCDONNELL PADRAIGOfficerSep 02 '25Proposed Sale124.882,000249,760Sep 02 03:30 PM
McMahon Robert W.Former OfficerAug 29 '25Proposed Sale124.9628,0813,508,993Aug 29 03:46 PM
Ancher-Jensen HenrikFormer OfficerAug 29 '25Proposed Sale125.0421,6442,706,366Aug 29 09:59 AM
MCDONNELL PADRAIGPresident and CEOAug 01 '25Sale113.452,000226,90035,448Aug 04 04:15 PM
MCDONNELL PADRAIGOfficerAug 01 '25Proposed Sale113.452,000226,900Aug 01 10:32 AM
MCDONNELL PADRAIGPresident and CEOJul 01 '25Sale117.441,508177,10037,448Jul 03 04:46 PM
MCDONNELL PADRAIGOfficerJul 01 '25Proposed Sale117.441,508177,100Jul 01 12:45 PM
Brown Judy LDirectorJun 18 '25Sale116.5389041,677Jun 23 12:12 PM
Last Close
Jun 03  •  04:00PM ET
28.56
Dollar change
-0.50
Percentage change
-1.72
%
ATLO Ames National Corp daily Stock Chart
Index
RUT
P/E
11.77
EPS (ttm)
2.43
Insider Own
1.99%
Shs Outstand
8.86M
Perf Week
-0.49%
Market Cap
252.96M
Forward P/E
10.13
EPS next Y
2.82
Insider Trans
0.71%
Shs Float
8.68M
Perf Month
1.10%
Enterprise Value
-
PEG
-
EPS next Q
0.65
Inst Own
40.55%
Perf Quarter
4.65%
Income
21.54M
P/S
2.54
EPS this Y
32.35%
Inst Trans
0.79%
Perf Half Y
32.10%
Sales
99.60M
P/B
1.22
EPS next Y
4.44%
ROA
1.00%
Perf YTD
24.39%
Book/sh
23.44
P/C
-
EPS next 5Y
-
ROE
11.03%
52W High
29.71 -3.87%
Perf Year
61.45%
Cash/sh
-
P/FCF
11.64
EPS past 3/5Y
0.05% 0.75%
ROIC
9.54%
52W Low
16.94 68.59%
Perf 3Y
54.21%
EV/EBITDA
-
Sales past 3/5Y
11.32% 5.96%
Gross Margin
-
Volatility
1.55% 2.04%
Perf 5Y
11.91%
EV/Sales
-
EPS Y/Y TTM
91.37%
Oper. Margin
27.43%
ATR (14)
0.59
Perf 10Y
15.56%
Quick Ratio
-
Sales Y/Y TTM
6.16%
Profit Margin
21.63%
RSI (14)
52.10
Current Ratio
0.37
EPS Q/Q
74.28%
SMA20
0.63%
Beta
0.30
Debt/Eq
0.26
Sales Q/Q
5.65%
SMA50
0.65%
Rel Volume
0.85
Prev Close
29.06
Employees
260
LT Debt/Eq
0.09
SMA200
17.76%
Avg Volume
59.47K
Price
28.56
IPO
Mar 31, 2000
Option/Short
Yes / Yes
Trades
Volume
51,067
Change
-1.72%
Jan-23-26 04:36PM
Oct-17-25 04:18PM
Aug-08-25 02:38PM
Apr-17-25 05:17PM
Apr-04-25 11:25PM
04:22PM Loading…
Jan-24-25 04:22PM
Aug-09-24 02:20PM
Jun-24-24 09:53AM
Apr-04-24 08:52AM
Jan-19-24 04:31PM
Dec-13-23 09:45AM
Aug-31-23 10:43PM
Aug-11-23 07:01AM
Aug-10-23 06:24AM
Aug-09-23 06:26AM
06:28AM Loading…
Aug-08-23 06:28AM
Aug-07-23 06:35AM
Aug-04-23 07:14AM
Aug-03-23 07:15AM
Aug-02-23 07:52AM
Aug-01-23 06:51AM
Jul-31-23 06:44AM
Jul-28-23 07:58AM
Jul-27-23 07:10AM
Jul-26-23 01:12PM
Jul-25-23 07:16AM
Jul-24-23 07:12AM
06:05AM
Jul-21-23 07:23AM
Jul-20-23 06:55AM
07:10AM Loading…
Jul-19-23 07:10AM
Jul-18-23 06:53AM
Jul-17-23 07:10AM
Jul-14-23 06:50AM
Jul-13-23 07:02AM
Jul-12-23 07:22AM
Jul-11-23 06:08AM
Jul-10-23 06:56AM
Jul-05-23 06:46AM
Jul-03-23 06:50AM
Jun-30-23 06:52AM
Jun-29-23 06:49AM
Jun-28-23 06:58AM
Jun-27-23 06:46AM
Jun-26-23 06:41AM
Jun-23-23 09:24AM
Jun-22-23 07:05AM
Jun-21-23 07:05AM
Jun-20-23 06:35AM
Jun-15-23 06:38AM
Jun-14-23 06:39AM
Jun-13-23 06:37AM
Jun-12-23 06:47AM
Jun-09-23 06:34AM
Jun-08-23 06:43AM
Jun-07-23 08:25AM
Jun-06-23 06:34AM
Jun-05-23 06:44AM
Jun-01-23 07:06AM
May-25-23 06:38AM
May-24-23 06:43AM
May-22-23 07:49AM
May-19-23 07:03AM
May-18-23 07:03AM
May-10-23 03:41PM
Apr-23-23 08:28AM
Apr-05-23 06:38AM
Mar-17-23 06:38AM
Jan-26-23 05:37AM
Jan-23-23 05:19AM
Jan-20-23 04:30PM
Jan-16-23 06:43AM
Oct-27-22 06:51AM
Oct-01-22 04:06PM
Sep-30-22 04:23PM
Jul-24-22 08:26AM
Jul-02-22 08:50AM
Mar-11-22 12:39PM
Feb-15-22 04:09AM
Jan-23-22 06:24AM
Dec-13-21 09:07AM
Oct-26-21 08:12AM
Oct-25-21 06:02AM
Oct-22-21 06:38AM
Jul-24-21 03:26AM
Jul-23-21 03:22PM
01:45AM
Jun-13-21 01:06PM
Apr-24-21 03:21AM
Apr-23-21 01:23AM
Mar-09-21 12:06AM
Dec-09-20 11:11AM
Nov-29-20 08:26PM
Oct-24-20 09:57AM
Sep-15-20 11:22AM
Jul-26-20 10:40AM
May-31-20 05:37PM
Apr-25-20 08:00AM
Mar-15-20 08:34AM
Jan-24-20 05:38AM
Ames National Corp. is a bank holding company, which engages in the provision of banking services through its subsidiaries. Its activities include personal, business, agricultural and commercial lending, management of the investment securities portfolio, deposit account services, and wealth management services. The company was founded on January 21, 1975 and is headquartered in Ames, IA.
PresidentMr. John P. Nelson
President & Director of First National BankMr. Scott T. Bauer
Chief Lending OfficerMr. Michael A. Wilson
CFO & SecretaryMr. Justin C. Clausen
Senior VP & Chief Information OfficerMr. Timothy J. Lupardus
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cassabaum Michelle RDirectorMay 29 '26Buy28.831704,9019,988May 29 02:23 PM
Hagan Patrick GDirectorMay 15 '26Buy27.692005,5389,600May 15 12:04 PM
Hagan Patrick GDirectorMay 12 '26Buy27.651002,7659,400May 12 10:39 AM
Cassabaum Michelle RDirectorApr 30 '26Buy28.08842,3599,818Apr 30 04:02 PM
Cassabaum Michelle RDirectorFeb 27 '26Buy27.252055,5869,734Feb 27 04:38 PM
Cassabaum Michelle RDirectorJan 30 '26Buy26.112807,3119,193Feb 02 04:43 PM
Trost Scot A.DirectorDec 10 '25Buy22.882004,5761,000Dec 10 04:23 PM
Bauer Scott TPresident of subsidiary bankDec 02 '25Buy21.68204344,009Dec 03 10:09 AM
Swartz Kevin LDirectorNov 21 '25Buy20.802004,1605,380Nov 24 10:45 AM
PUTZIER JEFFREY KPresident of subsidiary bankNov 17 '25Buy21.252004,2503,827Nov 19 02:59 PM
Beals Douglas WDirectorNov 13 '25Buy21.3750010,6852,950Nov 17 09:51 AM
Cassabaum Michelle RDirectorOct 31 '25Buy20.82449168,913Nov 03 11:40 AM
Hagan Patrick GDirectorOct 24 '25Buy20.853006,2559,300Oct 24 03:18 PM
Cassabaum Michelle RDirectorAug 29 '25Buy19.832785,5138,869Aug 29 01:23 PM
Cassabaum Michelle RDirectorJul 31 '25Buy18.291643,0008,591Aug 01 02:20 PM
Baker Jeffery CDirectorJun 20 '25Buy17.185008,5903,449Jun 23 04:52 PM
Johnson Dan EPresident of subsidiary bankJun 11 '25Buy17.752103,7281,558Jun 11 03:28 PM